Ahead of International Women's Day, Kristie Batten takes stock of the mining industry's progress on gender equality in the ...

Gold nabbed another month-end high, even if it failed to break its US$3000/oz ceiling, with rare earths and copper also on ...

Brazil is rising through the ranks as a key player in the global critical minerals scene, especially in lithium and rare ...

These companies are positioned to capture expected demand growth in high purity alumina, or HPA, which has a range of ...

The ASX has slipped (again) as the trade war chaos unfolds. WiseTech is scrambling to fill director spots and Virgin has a ...

Psilocybin is healing brains, boosting connections and tackling binge eating, and ASX players like Tryptamine and Bioxyne are ...

Litchfield's IP survey has found a large system at its Oonagalabi project in the NT that will be tested in upcoming drilling.

ASX dips with Trump’s tariffs and China stimulus in the mix, miners ease the pain but insurance stocks keep getting smashed.

Clarity Pharmaceuticals will move to the next stage of its phase II trial to test its isotope-based therapy on prostate ...

The S&P/ASX 200 Health Care Index fell 7.66% in February. Morgans healthcare analyst Iain Wilkie noted several factors ...

Gold stocks soared last month, with a host of precious metals hunters surging over 100% as prices hit record levels.